We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$50.8B
AUM Growth
-$294M
(-0.58%)
Cap. Flow
-$328M
Cap. Flow
% of AUM
-0.65%
Top 10 Holdings %
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$255M |
| 2 |
Textron
TXT
|
+$206M |
| 3 |
AstraZeneca
AZN
|
+$164M |
| 4 |
ExxonMobil
XOM
|
+$124M |
| 5 |
Moderna
MRNA
|
+$121M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$962M |
| 2 |
WORK
Slack Technologies, Inc.
WORK
|
+$204M |
| 3 |
Devon Energy
DVN
|
+$201M |
| 4 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$170M |
| 5 |
Carrier Global
CARR
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.3% |
| 2 | Healthcare | 15.98% |
| 3 | Financials | 14.49% |
| 4 | Consumer Discretionary | 11.52% |
| 5 | Communication Services | 8.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Expedia Group
EXPE
$37B
| $24.9M | 0.05% |
151,700
-2,200
| -1% | -$340K |
|
377
Thomson Reuters
TRI
$43.1B
| $24.9M | 0.05% |
213,541
-104,399
| -33% | -$12.2M |
|
378
LyondellBasell Industries
LYB
$20B
| $24.7M | 0.05% |
263,600
-4,100
| -2% | -$402K |
|
379
UDR
UDR
$12.2B
| $24.7M | 0.05% |
466,116
+23,189
| +5% | +$1.24M |
|
|
AMAM
380
DELISTED
Ambrx Biopharma Inc
AMAM
| $24.7M | 0.05% |
1,827,292
| – | – |
|
381
Tyson Foods
TSN
$20.6B
| $24.6M | 0.05% |
311,255
-4,500
| -1% | -$340K |
|
|
IAA
382
DELISTED
IAA, Inc. Common Stock
IAA
| $24.6M | 0.05% |
450,000
+350,000
| +350% | +$19.4M |
|
383
Tractor Supply
TSCO
$17.8B
| $24.5M | 0.05% |
605,500
-9,000
| -1% | -$349K |
|
384
WEC Energy
WEC
$35B
| $24.5M | 0.05% |
277,508
+165,100
| +147% | +$15.5M |
|
|
EQRX
385
DELISTED
EQRx, Inc. Common Stock
EQRX
| $24.4M | 0.05% |
2,459,685
-40,315
| -2% | -$403K |
|
|
GRMN
386
Garmin
GRMN
$58.6B
| $24.3M | 0.05% |
156,616
-2,300
| -1% | -$374K |
|
387
Keysight
KEYS
$57.9B
| $24.3M | 0.05% |
148,135
-21,539
| -13% | -$3.62M |
|
|
CTLT
388
DELISTED
CATALENT, INC.
CTLT
| $24.3M | 0.05% |
182,600
-2,600
| -1% | -$325K |
|
389
Nasdaq
NDAQ
$52.4B
| $24.2M | 0.05% |
376,740
+12,900
| +4% | +$812K |
|
390
Armstrong World Industries
AWI
$7.78B
| $24.2M | 0.05% |
+253,197
| New | +$26.5M |
|
391
Dollar Tree
DLTR
$24.8B
| $23.7M | 0.05% |
247,849
-3,600
| -1% | -$346K |
|
392
Telos
TLS
$343M
| $23.4M | 0.05% |
825,000
-60,000
| -7% | -$1.81M |
|
393
Allegro MicroSystems
ALGM
$7.97B
| $23.4M | 0.05% |
733,473
+254,506
| +53% | +$7.5M |
|
|
LITT
394
DELISTED
Logistics Innovation Technologies Corp. Class A Common Stock
LITT
| $23.4M | 0.05% |
+2,400,000
| New | +$23.3M |
|
|
UHG
395
DELISTED
United Homes Group
UHG
| $23.3M | 0.05% |
2,400,000
| – | – |
|
396
Ventas
VTR
$47.2B
| $23.2M | 0.05% |
420,400
+13,900
| +3% | +$796K |
|
397
ReNew
RNW
$2.26B
| $23.2M | 0.05% |
+2,274,595
| New | +$22.7M |
|
398
International Paper
IP
$21.7B
| $23.1M | 0.05% |
435,592
+393,677
| +939% | +$21.9M |
|
399
Corpay
CPAY
$25.6B
| $23.1M | 0.05% |
88,258
+14,950
| +20% | +$3.87M |
|
|
IMPX
400
DELISTED
AEA-Bridges Impact Corp
IMPX
| $23.1M | 0.05% |
2,357,540
| – | – |
|
Similar funds
Adage Capital Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
- Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
- Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
- Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
- Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
- Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
- Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.
Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.